Misoprostol vaginal insert: Phase II data

In a double-blind, dose-finding, U.S. Phase II trial in 374 women undergoing cervical ripening and induction of labor, the 200 ug misoprostol vaginal insert (MVI 200) significantly reduced time to vag...